Home › Funds › Millennium Management › STRO
Millennium Management position in STRO
SUTRO BIOPHARMA INC · Health Care
Latest position (Q2 2026)365.97K sh
Reported value held$12.15M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 214.58K | $4.05M | New |
| Q4 2021 | 145.63K | $2.17M | Reduce |
| Q1 2022 | 342.13K | $2.81M | Add |
| Q2 2022 | 2.41M | $12.56M | Add |
| Q3 2022 | 2.54M | $14.08M | Add |
| Q4 2022 | 1.37M | $11.06K | Reduce |
| Q1 2023 | 891.62K | $4.12K | Reduce |
| Q2 2023 | 1.50M | $6.99M | Add |
| Q3 2023 | 1.24M | $4.30M | Reduce |
| Q4 2023 | 1.54M | $6.59M | Add |
| Q1 2024 | 4.74M | $26.76M | Add |
| Q2 2024 | 4.36M | $12.78M | Reduce |
| Q3 2024 | 2.03M | $7.03M | Reduce |
| Q4 2024 | 405.62K | $746.34K | Reduce |
| Q1 2025 | 703.15K | $457.47K | Add |
| Q2 2025 | 4.73M | $3.38M | Add |
| Q3 2025 | 4.52M | $3.93M | Reduce |
| Q4 2025 | 418.20K | $4.84M | Reduce |
| Q1 2026 | 210.38K | $5.24M | Reduce |
| Q2 2026 | 365.97K | $12.15M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding STRO
- BlackRock Inc 1.12M sh · $37.27M · Q2 2026
- Balyasny Asset Management 711.16K sh · $23.61M · Q2 2026
- Geode Capital Management 389.69K sh · $12.94M · Q2 2026
- Point72 Asset Management 237.83K sh · $7.90M · Q2 2026
- UBS Group AG 208.51K sh · $6.92M · Q2 2026
- Two Sigma Investments 201.69K sh · $6.70M · Q2 2026
- Marshall Wace 175.25K sh · $5.82M · Q2 2026
- JPMorgan Chase & Co 159.63K sh · $5.32M · Q2 2026
- Goldman Sachs Group 149.22K sh · $4.95M · Q2 2026
- Vanguard Group 375.79K sh · $4.35M · Q4 2025
- Northern Trust Corp 125.93K sh · $4.18M · Q2 2026